Percutaneous Treatment of a Jejunovaginal Fistula Using a Combination of the Amplatzer Vascular Plug II and N-Butyl-2-Cyanoacrylate: A Case Report

complications, inflammatory bowel disease, pelvic malignancy, pelvic irradiation, pelvic surgery, or other traumatic causes (1-4). Also, it may cause distressing symptoms including vaginal discharge with vaginitis, continual leakage of flatus and feces through the vagina, severe skin excoriation, as well as incontinence and dysparenunia. Treatment for an enterovaginal fistula depends on the location of intestinal fistula. Most rectovaginal fistulas develop at the lower third of the vagina can be treated surgically (5). Jejunovaginal fistulas can be expected to spontaneously close during conservative management. The use of the Amplatzer vascular plug (AVP; AGA Medical, Golden Valley, MN, USA), a recently available embolic device derived from the Amplatzer septal occluder, has been shown to be safe and effective for the treatment of various cardiopulmonary vascular diseases. We report the first use of the AVP II and the use of an N-butyl-2-cyanoacrylate (NBCA)-lipiodol mixture for treatment of a patient with a jejunovaginal fistula which failed to close following conservative management.